---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-014240"
form_type: "8-K/A"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2024-04-10T23:59:59+00:00"
generated_at: "2026-06-04T00:35:57.613144+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tevogen Bio raises $6.0M via Series A-1 Preferred Stock sale to existing investor

## Summary
- Sold 600 shares of Series A-1 Preferred at $10,000/share to Patel Family, LLP, affiliated with >5% holder Dr. Manmohan Patel.
- Preferred converts into 600,000 common shares; carries 5% cumulative dividend, increasing 2%/yr, max 15%.
- Company has call right to redeem at $10,000 plus accrued dividends if 20-day VWAP exceeds $5.00 and registration effective.
- Series A-1 Preferred ranks pari passu with Series A Pref and senior to common and Series B on liquidation.
- Amendment corrects omission of Item 3.02 disclosure; original filing on March 27, 2024 is restated.

## SEC filing metadata
- accession: 0001493152-24-014240
- form_type: 8-K/A
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2024-04-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.02, 1.01, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000149315224014240/0001493152-24-014240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000149315224014240/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-014240
- JSON: https://secwatch.observer/filing/0001493152-24-014240.json
- Plain text: https://secwatch.observer/filing/0001493152-24-014240.txt

## Key facts
- Governance Changes
  Tevogen Bio Holdings Inc.: Filed Certificate of Designation for Series A-1 Preferred Stock, creating new series and establishing rights, preferences, and terms (effective 2024-03-28).
  - Change: charter amendment
  - Effective: 2024-03-28
  source text: On March 28, 2024, the Company filed the Certificate of Designation of Series A-1 Preferred Stock (the “Series A-1 Certificate of Designation”) with the Delaware Secretary of State, creating the Series A-1 Preferred Stock and establishing the rights, preferences and other terms of the Series A-1 Preferred Stock, and issued the Series A-1 Preferred Stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860871/000149315224014240/0001493152-24-014240-index.htm
- Material Agreements
  Tevogen Bio Holdings Inc. amended Amended and Restated Securities Purchase Agreement with an investor valued at aggregate purchase price of $6.0 million (effective 2024-03-27).
  - Action: amendment
  - Agreement: equity purchase
  - Counterparty: an investor
  - Value: aggregate purchase price of $6.0 million
  - Effective: 2024-03-27
  source text: On March 27, 2024, the Company and the Investor entered into an Amended and Restated Securities Purchase Agreement, pursuant to which the parties amended and restated the Original Agreement and the Investor agreed to purchase 600 shares of Series A-1 Preferred Stock of the Company for an aggregate purchase price of $6.0 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860871/000149315224014240/0001493152-24-014240-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.